Advertisement

Topics

Prana Company Profile

09:00 EDT 19th September 2018 | BioPortfolio

Nil

Location

3275 Corporate View
Vista
California
92081
United States of America

Contact

Phone: 760.566.1070
Fax: 760.566.1071
Email: info@prana.com


News Articles [13 Associated News Articles listed on BioPortfolio]

Prana receives approval for Phase l trial of PBT434

Prana Biotechnology has received approval from the ethics committee to begin a Phase I clinical trial to investigate the safety,...Read More... The post Prana receives approval for Phase l trial of PB...

Prana doses first subject in Phase l trial of PBT434

Prana Biotechnology has dosed the first cohort of subjects in its Phase I clinical trial of PBT434 for the treatment...Read More... The post Prana doses first subject in Phase l trial of PBT434 appear...

Prana Biotechnology (PRAN) Lifted to Hold at ValuEngine

Separately, B. Riley set a $4.00 target price on Prana Biotechnology and gave the company a buy rating in a research report on Friday, January 5th. Shares of PRAN stock traded up $0.07 on Wednesday, h...

Prana to initiate phase 1 trial of PBT434 to treat Parkinsonian diseases

Prana Biotechnology Ltd has received ethics committee approval and has commenced recruitment for its phase I clinical trial evaluating the safety, tolerability and pharmacokinetics of the company's le...

Professor Ira Shoulson, Georgetown University & Prana Biotechnology

Professor Ira Shoulson, Georgetown University & Prana Biotechnology

First Volunteers Dosed in Phase I Clinical Trial of PBT434, Prana’s Lead Therapy for ...

Highlights: Read more...

PBT434 Data to be Presented at the International Congress of Parkinson’s Disease and Movement ...

Prana’s PBT434 prevents neuronal loss in a new model of neurodegeneration Read more...

First Volunteers Dosed in Phase I Clinical Trial of PBT434, Prana’s Lead Therapy for Parkinsonian Diseases

Highlights: Prana enrols and doses its first cohort of healthy volunteers in its Phase I clinical trial Evidence supports activity of PBT...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Prana Biotechnology Limited

Prana Biotechnology was established to commercialise research into Alzheimer's disease and other major age-related neurodegenerative disorders. The Company was incorporated in 1997 and listed on the A...

Prana Biotechnology Ltd

Prana’s lead candidate, PBT434, is the first of a new generation of small molecules designed to inhibit the aggregation of pathological proteins implicated in neurodegenerati...

Prana Biotechnology

Prana Biotechnology has developed a proprietary library of class-leading chemical compounds. This library is combined with a drug development program to explore novel therapeutics in multiple disease ...

Prana

Nil

More Information about "Prana" on BioPortfolio

We have published hundreds of Prana news stories on BioPortfolio along with dozens of Prana Clinical Trials and PubMed Articles about Prana for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prana Companies in our database. You can also find out about relevant Prana Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record